昂利康：关于获得药品注册证书的公告

Group 1 - The core point of the article is that Anglikon has received the drug registration certificate for Sitagliptin Metformin Extended-Release Tablets from the National Medical Products Administration [2] Group 2 - The announcement was made on the evening of July 31 [2] - The drug registration certificate is a significant regulatory milestone for the company [2] - This development may enhance the company's product portfolio in the diabetes treatment market [2]